Belgian Society of Cardiology
The Belgian Society of Cardiology is a member of the European Society of Cardiology
Key information
- Number of Members: 448
- Year of foundation: 1935
- ESC Member since: 1950
Objectives: To promote research and education in the field of cardiology through the Belgian cardiological community.
The Belgian Society of Cardiology coordinates the activities of several working groups.
It organises an annual scientific meeting every year at the end of January/beginning of February.
Journal
"Acta Cardiologica" is the official journal of the Belgian national society. Published since 1946 in English, there are six issues per year. Print and online versions are available and the journal is indexed in PubMed, Current Contents, EMBASE, Index Medicus and Medline.
More information
Rue des Champs Elysées 63 - B-1050 Brussels, Belgium +3226446232
Board
Professor Rik Willems
President
Assistant Professor Bernhard Gerber
Past President
Doctor Frank Cools
Treasurer
Professor Antoine Bondue
President-Elect
Working Groups
- Belgian Working Group on Interventional Cardiology (BWGIC)
- Belgian Heart Rhythm Association (BeHRA)
- Belgian Working Group on Non-invasive Cardiac Imaging (BWGNICI)
- Belgian Working Group on Heart Failure (BWGHF)
- Belgian Working Group on Cardiovascular Prevention and Rehabilitation (BWGCPR)
- Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC)
- Belgian Working Group on Adult Congenital Heart Disease (BWGACHD)
- Belgian Council on Hypertension and Vascular Biology (statutes pending)
- Belgian Working Group on Cardiovascular Nursing (BWGCVN)
- Belgian Working Group Basic Research in Cardiology (BWGBRC)
- Young Cardiologists Club (YCC)
Upcoming event
ESC Clinical Practice Guidelines endorsed by your National Society
2025 ESC/EACTS Guidelines for the management of valvular heart disease
The 2025 ESC/EACTS Guidelines for the management of valvular heart disease (VHD) are an update of the 2021 version of this document.
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
This 2025 Focused Update addresses changes in recommendations for the treatment of dyslipidaemias based on new evidence published since the 2019 version, up until 31 March 2025.
2025 ESC Guidelines for the management of myocarditis and pericarditis
These guidelines introduce a comprehensive, patient-oriented framework for the diagnosis and management of IMPS, spanning the full disease spectrum.
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease
This clinical consensus statement on mental health and cardiovascular disease highlights the multidirectional relationship between mental health, cardiovascular health and cardiovascular disease and its impact on cardiovascular risk and prognosis.
2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
Our guidelines support healthcare professionals with the diagnosis and management of elevated blood pressure and hypertension.
2024 ESC Guidelines for the management of atrial fibrillation
In this iteration of the European Society of Cardiology (ESC) Clinical Practice Guidelines on Atrial Fibrillation, the task force has consolidated and evolved past approaches to develop the AF-CARE framework.
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
These guidelines provide a comprehensive framework for healthcare professionals, covering the entire PAAD patient journey.
2024 ESC Guidelines for the management of chronic coronary syndromes
The current guidelines for managing chronic coronary syndromes (CCS) are intended to assist in diagnosing and initiating treatment for individuals with suspected CCS, as well as in the longterm management of patients with confirmed CCS.
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
The current Guidelines on cardiovascular disease and diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes.
2023 ESC Guidelines for the management of endocarditis
2023 ESC Guidelines for the management of acute coronary syndromes
The present guideline has been developed to support healthcare professionals in the diagnosis and management of patients presenting with acute coronary syndrome (ACS). For the first time, the present guideline presents recommendations for management of patients across the entire spectrum of ACS in one document.
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, there have been several randomised controlled trials that should change patient management ahead of the next scheduled full guideline.
2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice
The present guidelines have been developed to support healthcare professionals in their efforts to reduce the burden of ASCVD in both individual patients, as well as at a population level.
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
The 2021 ESC Guidelines redefine cardiac pacing – covering CRT, His and left bundle branch pacing, advanced diagnostics, risk reduction, remote monitoring, and shared decision-making for better patient care.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence. Fortunately, we now have a wealth of clinical trials to help us select the best management to improve the outcomes for people with HF; for many, it is now both preventable and treatable.
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
These guidelines draw upon existing ESC Guidelines for the investigation, risk assessment, and management of individuals with CVD to aid physicians when prescribing exercise programmes or providing advice for sports participation.
2020 ESC Guidelines for the management of Adult Congenital Heart Disease (previously Grown-Up Congenital Heart Disease)
Decision-making in ACHD involves accurate diagnosis, timing of intervention, risk assessment, and selection of the most suitable type of intervention.
2019 Guidelines on Supraventricular Tachycardia
Our guidelines deliver updated, evidence-based recommendations for managing supraventricular tachycardias – covering drug therapy, ablation, and coexisting conditions.
2019 Guidelines on Acute Pulmonary Embolism (Diagnosis and Management of)
This document follows the previous ESC guidelines focusing on the clinical management of pulmonary embolism (PE) published in 2000, 2008, and 2014.
2019 ESC/EAS Guidelines for the management of dyslipidaemias
These ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification.
2018 ESC/EACTS Guidelines on Myocardial Revascularisation
These Guidelines represent the third time that the ESC and EACTS have brought together cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body of evidence, with the mission of drafting balanced, patient-centred practice Guidelines on myocardial revascularisation.
2018 Guidelines on Fourth Universal Definition of Myocardial Infarction
The 2018 ESC Guidelines refine the Universal Definition of MI – distinguishing myocardial injury from infarction with high-sensitivity biomarkers and clear clinical criteria.
2018 Guidelines for Diagnosis/Management of Syncope
Guidance on how to evaluate patients with loss of consciousness (LOC) and how to perform and interpret tests properly: tracings, videos, flow charts, and checklists are provided.